Isolated monoclonal antibodies binding to specific sites of the human pathway inhibitor (tissue factor pathway inhibitor) are provided. TFPI) as well as the isolated nucleic acid molecules coding the above antibodies. Pharmaceutical compositions containing:Anti-TFPI monoclonal antibodies and methods for treating defects or defects in coagulation with antibodies.
展开▼